BLFS Stock Analysis: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$28.10
-0.08 (-0.28%)
▼
5d:
+1.12%
30d:
+5.4%
90d:
+42.35%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLFS shows positive signals but monitor for confirmation. Market pricing in 8.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BLFS shows positive signals but monitor for confirmation. Market pricing in 8.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $28.10, which is considered slightly high relative to its 30-day fair value range of $25.94 to $28.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 85.2) compared to its historical average (110.1). Remarkably, the market is currently pricing in an annual earnings decline of 8.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLFS is in a strong uptrend. Immediate support is located at $26.98, while resistance sits at $30.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (26th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.11 (+14.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLFS is in a strong uptrend. Immediate support is located at $26.98, while resistance sits at $30.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (26th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.11 (+14.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$25.94 -
$28.17
Company Quality Score
61/100
(BUY)
Options IV Signal
26th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- BULLISH: Options cheap (IV 26th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($32.11)
Trading Range Analysis
30-Day Trading Range
$25.94 -
$28.17
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$2.69
(9.6%)
Support & Resistance Levels
Support Level
$26.98
Resistance Level
$30.00
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
85.15
Wall Street Target
$32.11
(+14.3%)
Revenue Growth (YoY)
24.7%
Earnings Growth (YoY)
-13.9%
Profit Margin
-2.9%
Valuation Discount vs History
-8.2% cheaper
PE vs Historical
85.2 vs 110.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.2%
(market-implied from PE analysis)
1-Year Target
$25.80
(-8%)
2-Year Target
$23.68
(-16%)
3-Year Target
$21.74
(-23%)
3-Yr Target (if PE normalizes)
(PE: 85→110)
$28.11
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 85.2, Growth: 32.0%)
$64.63
(+130%)
Base:
(SPY PE: 21.8, Growth: 32.0%)
$16.53
(-41%)
Bear:
(PE: 18.5, Growth: 32.0%)
$14.05
(-50%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 85.2 to 110.1
Stabilization Target:
$36.33
(+29.3%)
PE Expansion Potential:
+29.3%
Share & Embed Analysis
Last updated: July 13, 2026 10:25 PM ET
Data refreshes hourly during market hours. Next update: 11:25 PM
Data refreshes hourly during market hours. Next update: 11:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Karen A Foster
SELL
500 shares
2026-03-09
Karen A Foster
SELL
96923 shares
2026-03-05
Aby J Mathew
SELL
529 shares
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$562 | 63 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$177 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$366 | 63 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 61 BUY |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
